Malin Corporation PLC is focused on investing in life sciences companies. The Company’s assets give investors access to life sciences businesses with exposure across diverse modalities, therapeutic areas and geographies. Its business includes Poseida, Viamet, Xenex, WaveBreak, KNOW Bio, and Artizan. Poseida is a clinical-stage biopharmaceutical company building a pipeline of Chimeric antigen receptor T cell (CAR-T) product candidates. Xenex is a commercial-stage medical device company focused on reducing healthcare-associated infections with its non-mercury, full-spectrum disinfection LightStrike Germ-Zapping robots. KNOW Bio is a life science company engaged in the fields of nitric oxide and precision light therapy. WaveBreak Therapeutics company focuses on the development of medicines for the treatment of protein-misfolding diseases including Alzheimer's and Parkinson's. Artizan is a biotechnology company.
Company Information
About this company
Key people
Neil McLoughlin
General Counsel, Company Secretary
Fiona Dunlevy
Executive Director
David Dobrosky
Senior Analyst
Peter A. Schwartzman
Member of Senior Management Team
Liam Daniel
Non-Executive Chairman of the Board
Luke Corning
Non-Executive Director
Jean-Michel Cossery
Non-Executive Director
Kirsten Aarup Drejer
Non-Executive Director
Owen P. Hughes
Non-Executive Director
Click to see more
Key facts
- Shares in issue4.33m
- EPICMLC
- ISINIE00BVGC3741
- LocationIreland
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap€34.61m
- Employees2
- ExchangeIrish Stock Exchange
- IndexISEQ Overall Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.